22 February 2010 in Vision Research
18 January 2025 in The Journal of Heart and Lung Transplantation
30 March 2022 in Circulation: Cardiovascular Imaging
25 March 2018 in Pediatric Transplantation
12 November 2020 in ASAIO Journal
Discharging children on ventricular assist device (VAD) support offers advantages for quality of life. We sought to describe discharge and readmission frequency in children on VAD support. All VAD-implanted patients aged 10–21 years at Advanced Cardiac Therapies Improving Outcomes Network (ACTION) centers were identified from the Pediatric Health Information System database (2009–2018). Discharge frequency on VAD was calculated. Patients discharged on VAD were compared with those not discharged. Freedom from readmission was assessed using the Kaplan–Meier method. A total of 298 VAD-implanted patients from 25 centers were identified, of which 163 (54.7%) were discharged. Discharges increased over time (36.9% [2009–2012] vs. 59.7% [2013–2018], p = 0.001). Of 144 discharged patients with follow-up, 96 (66.7%) were readmitted for reasons other than transplantation. Heart failure was the most common reason for readmission (27.7%), followed by infection (25.8%) and hematologic concerns (16.8%). In-hospital mortality on readmission was uncommon (1.8%) and the median length of stay was 6 days (interquartile range 2–19 days). Discharge of children on VAD support has increased over time, although variability exists across centers. Readmissions are common with diverse indications; however, the risk of mortality is low. Further interventions, including collaboration in ACTION, are critical to increasing discharges and optimizing outpatient management.
11 February 2015 in Congenital Heart Disease
Catheter ablation of the slow atrioventricular (AV) pathway has been shown to be safe and effective in pediatric patients with atrioventricular nodal reentrant tachycardia (AVNRT). Despite that, acute success is not guaranteed, and safety of ablating near the AV node remains a concern. A retrospective analysis was performed of all AVNRT ablations using the Ensite NavX voltage mapping technique at our institution. Each map was reviewed with patient and NavX computer data recorded. To account for a learning curve, each map was idealized and compared with the original map. Procedure and fluoroscopy time were compared with a control group. Twenty-eight patients underwent catheter ablation for AVNRT from September 2011 until December 2012 using the voltage mapping technique. The historical control group comprised 24 patients who underwent catheter ablation using the electroanatomic approach. There was 96% acute success with one recurrence in the voltage mapping group, at a mean follow-up of 24 months. The slow pathway was visualized in 86% of patients at the time of ablation, while three of four without could be found on idealization of the voltage map. Mean high- and low-voltage parameters increased with idealization, but showed no correlation with age, gender, or weight. Estimated pathway size had significant inter-patient variability. Procedure and fluoroscopy times did not vary significantly compared with controls. Visualization of the AV nodal slow pathway in a pediatric population is possible using voltage mapping technique with the potential to increase safety and efficacy. Variability exists in the voltage parameters needed to visualize individual slow pathways, which leads to a distinct learning curve.